East India Pharma Unlisted Share Price

About EAST INDIA PHARMACEUTICAL WORKS LIMITED Unlisted Shares 

East India Pharmaceutical Works Limited (EIPW) is one of the oldest pharmaceutical companies in India, Founded on 27 April 1936, it is involved in the Manufacturing of Healthcare Products. It is registered at the Registrar of Companies in Kolkata. The authorized equity share capital of the company is Rs. 10,00,00,000 and the paid-up capital is Rs. 6,67,45,180.

The Company has over 87 years of experience and has a focused “people-centric approach” which enabled it to evolve with ever-changing healthcare needs and it offers high-quality advanced medicines for modern-day health complexities.

Along with its high-quality products and experienced medical and research team, backed by the most advanced and precise equipment and infrastructure, the company ensures international quality standards at every stage of production. East India Pharmaceutical is focused on using cost-effective processes to produce high-volume formulations. The company has achieved GMP, WHO-GMP, and GLP certifications.

East India Pharma Share Price, Share Details as of March 31, 2025

INCORPORATION DETAILS

PARTICULAR OF SUBSIDIARY COMPANIES

BOARD OF DIRECTORS

Mr. Debarshi Duttagupta (Managing Director)

Mrs. Satarupa Mukherjee (Executive Director)

Mr. Probir Roy (Chairman)

Mr. Dilip Samadar (Member)

Prof. (Dr.) Suman Kumar Mukerjee

Mr. Sukamal Chandra Basu (Member)

Dr. Abhijit Banerjee

Dr.Tapas Raychaudhury

Mrs. Indrani Sen

Mrs. Sanghamitra Duttagupta

Mrs. Trishna Guha

 Principal Business Activities of the Company

SHAREHOLDING PATTERN (As of 31-03-2025)

Industry Outlook

The company is one of the oldest pharmaceutical companies in India that develops, manufactures, and markets high-quality medicines. The company has two manufacturing plants, one in Durgapur and one in Kolkata, with cutting-edge production facilities. The rapid spread of the COVID-19 pandemic had a significant impact on global economic activity. In India, like other countries around the world, has been severely impacted. IMF forecasts a 4.5 percent contraction in India for 2021. Finance Minister announced an additional outlay of Rs. 1,97,000 crore (USD 26,578.3 million) for the pharmaceutical Production Linked Incentive (PLI) scheme.

FAQ's on East India Pharma

Q: What is the face value of East India Pharmaceutical Works Ltd shares?
Answer: The face value of East India Pharmaceutical Works Ltd is ₹10 per equity share.

Q: How can I buy East India Pharmaceutical unlisted shares through WWIPL?
Answer: Investors can complete the KYC process, confirm the transaction details with WWIPL, transfer funds, and receive shares directly in their Demat account.

Q: Why should I buy East India Pharmaceutical shares through WWIPL?
Answer: WWIPL offers transparent pricing, secure transactions, seamless Demat transfers, and dedicated support throughout the investment process.

Q: Is investing in East India Pharmaceutical Works Ltd a good idea?
Answer: Investors often evaluate East India Pharmaceutical based on its long operating history, established pharmaceutical manufacturing capabilities, and presence in both domestic and international healthcare markets.

Q: Why do investors buy East India Pharmaceutical shares before a potential IPO?
Answer: Investors seek early exposure to an established pharmaceutical company before listing, aiming to participate in potential value creation and future liquidity events.

Q: What business does East India Pharmaceutical Works Ltd operate in?
Answer: The company manufactures bulk drugs, pharmaceutical formulations, and healthcare products, with capabilities in organic chemical synthesis, herbal products, microbiology, biotechnology, and analytical research.

Q: What makes East India Pharmaceutical different from other unlisted pharmaceutical companies?
Answer: Founded in 1936, East India Pharmaceutical is one of India's oldest pharmaceutical companies and has WHO-GMP, GMP, and GLP-certified manufacturing facilities with over eight decades of industry experience.

Q: What are the key growth drivers for East India Pharmaceutical Works Ltd?
Answer: Growth in healthcare demand, increasing pharmaceutical consumption, expansion of branded formulations, and government support for domestic pharmaceutical manufacturing are key growth drivers.

Q: What factors affect the valuation of East India Pharmaceutical shares?
Answer: Revenue growth, profitability, product portfolio, manufacturing capacity, regulatory compliance, and demand for pharmaceutical products are key valuation drivers.

Q: Are East India Pharmaceutical shares available in Demat form?
Answer: Yes. Shares purchased through WWIPL are transferred directly to the investor's Demat account.

Q: Can I sell my East India Pharmaceutical shares through WWIPL?
Answer: Yes. WWIPL facilitates both buying and selling of unlisted shares, subject to market demand and share availability.

Q: What documents are required to buy East India Pharmaceutical shares through WWIPL?
Answer: Investors generally need PAN, Aadhaar, Client Master Report (CMR), and bank account details to complete the transaction.

Q: What are the risks of investing in East India Pharmaceutical shares?
Answer: Investors should consider regulatory changes, pricing pressures, competition in the pharmaceutical industry, raw material cost fluctuations, and liquidity constraints associated with unlisted shares.

Q: How does WWIPL help investors track East India Pharmaceutical investments?
Answer: WWIPL provides company updates, transaction assistance, market information, and investment insights to help investors stay informed.

Q: How long does it take for East India Pharmaceutical shares purchased through WWIPL to be credited to a Demat account?
Answer: Shares are generally transferred to the investor's Demat account after successful completion and verification of the transaction.

Q: What should investors evaluate before investing in East India Pharmaceutical Works Ltd?
Answer: Investors should assess the company's financial performance, manufacturing capabilities, product portfolio, profitability, valuation, and long-term growth prospects.

Q: Can East India Pharmaceutical benefit from India's growing pharmaceutical industry?
Answer: Yes. Rising healthcare expenditure, increasing demand for medicines, government support for domestic pharmaceutical manufacturing, and export opportunities may create long-term growth opportunities for the company.